PCN12 EFFICACY OF SECOND LINE TREATMENTS IN PATIENTS WITH METASTATIC HORMONE REFRACTORY PROSTATE CANCER (MHRPC) IS NOT DEMONSTRATED BY PUBLISHED EVIDENCE FROM NONRANDOMIZED TRIALS
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)71909-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)71909-X/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
72
First Page :
A253
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71909-X&doi=10.1016/S1098-3015(11)71909-X